Answers are grounded in this paper and cite their sources.
Research reveals a stereoselective process for synthesizing collinoketones in complex substrates, indicating potential for neuroprotective applications.
Cycloadditions are among the most powerful reactions for constructing molecular complexity. The archetypal example is the [4+2] (Diels–Alder) cycloaddition, which efficiently furnishes cyclohexene derivatives. In comparison, the [6+4] cycloaddition, which forms cyclodecatriene derivatives from triene and diene reactants, is far less common. Here, we report a short and stereoselective synthesis of a highly unsaturated macrolactone that has been proposed as a biosynthetic precursor of the tricyclic cyclodecatriene collinoketone A and the neuroprotective natural product collinolactone. We find that this macrolactone undergoes effective transannular [6+4] cycloaddi-tions to afford stereoisomers of collinoketone A, which we name collinoketones B and C. Our work reassigns the structure of the natural product reported as collinoketone A and highlights the complexity of [6+4] cycloadditions with conformationally flexible substrates.
No takes yet. Share an insight, caveat, or question.
Reiter et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: